A Chinese GPU Maker Blacklisted by Washington Is Going Back to Investors for the Third Time in Eight Months. It's Raised $2.6 Billion Since January.

Third trip to the same well in eight months, and investors are still lining up.

Bloomberg reported on September 15 that banks have begun quietly sounding out investors for a new share placement by Shanghai Biren Technology worth roughly $1 billion — the Chinese GPU maker's third capital raise in eight months since its Hong Kong debut. Biren has been on the US Entity List since October 2023, restricting its access to advanced chipmaking tools, yet investor demand for the stock has been unaffected: its January 2 IPO priced at HK$19.60 a share and surged as much as 76% to 82% on its first day, oversubscribed more than 2,300 times by retail investors, pushing its market cap past $11 billion.

The pattern since then has been consistent: list, raise, watch the stock pop, come back for more. A mid-2026 follow-on placement of 153 million new H-shares at HK$46.2 apiece raised roughly HK$7.07 billion — about $892.5 million — with Biren agreeing to a standard 90-day lock-up that expires in early October, timing that lines up precisely with this new round reportedly under discussion. Combined with the original $717 million IPO, Biren will have raised roughly $2.6 billion across three rounds inside a single calendar year, from a company still recording steep losses — its total loss for the first half of 2025 alone rose 32.3% year over year to nearly 9 billion yuan.

Not every Chinese AI capital raise is landing the same way. Chinese AI lab Z.AI separately raised HK$39 billion this month through a combined Hong Kong share placement and convertible bond sale — and its shares slumped 9% the very next day, the opposite reaction to Biren's repeated pops. The split suggests investors are growing more selective even within a red-hot category: rewarding hardware plays racing to build domestic Nvidia alternatives, while starting to question richly priced raises at the model layer, the same distinction this newsletter has traced through YMTC's IPO and Moonshot's pending listing in recent weeks.

Export controls designed to slow Biren's access to advanced chipmaking equipment have not slowed its access to capital at all — if anything, the Entity List designation has become a footnote investors are pricing straight through. Whether that reflects genuine confidence in Biren's technology roadmap, or simply the same pattern this newsletter has already traced at YMTC and Moonshot — capital markets rewarding scarcity and narrative faster than they can verify the underlying product — is the question that won't get answered until Biren actually has to compete on performance rather than on being first to list.